Organ and Tissue Transplantation and the Catholic Moral Tradition: A Case Study in the Evolution of Moral Teaching

John Kleinsman
Issue 19, August 2006

"For Christians, Jesus' offering of himself is the essential point of reference and inspiration of the love underlying the willingness to donate an organ, which is a manifestation of generous solidarity."

--Pope John Paul II, 1992

John Paul II's description of organ and tissue donation in terms of the sacrificial love of Jesus Christ highlights the acceptability of organ transplantation within the Catholic Tradition. Yet, when it was first raised as a serious issue in the 1940's and 1950's, the morality of organ donation caused vigorous debate among Catholic moral theologians. Ashley and O'Rourke (1989, p.305) note that initially the question was discussed from a largely theoretical point of view because, prior to 1950, transplants were contemplated but not yet possible. The subject was therefore not included in the moral manuals of the time. However, as advances in medical science and surgical procedures made organ transplantation a viable option, ethicists and moralists were forced to give the matter closer scrutiny.

There are basically two types of organ donation possible – from a dead person to a living person and from a living donor to another living person. This article will trace the development of Catholic thinking about organ and tissue transplantation over the last sixty years.

Organ Transplantation from a Dead Person to a Living Person

The Catholic moral tradition, along with most other religious groups, readily endorsed the worth and ethical acceptability of transplanting organs from a dead person to a living person. Pius XII was an articulate spokesperson for the development of Church thinking on this matter. On May 14, 1956, in an allocution to a group of eye specialists, Pius XII informed his audience: "The public must be educated. It must be explained with intelligence and respect that to consent explicitly or tacitly to serious damage to the integrity of the corpse in the interest of those who are suffering, is no violation of the reverence due to the dead." He was clear that the practice of organ retrieval from dead persons should not be forbidden. Persons are free to "dispose of their bodies and to destine it to ends that are useful, morally irreproachable and even noble." In fact, Pius XII concluded, "This decision should not be condemned, but positively justified." (Tissue Transplantation. (May 14, 1956), in The Human Body: Papal Teachings, pp. 380-83.) In taking this stance Pius XII had in mind the needs of "medical science and the training of future physicians" as well as those with "the desire to aid the sick and the suffering."

Nevertheless, Pius XII's endorsement was not without its concerns. A key concern was that the body not be treated merely as a physical or biological entity. The human body deserves to be regarded differently than the body of an animal because human persons are formed in the image and likeness of God, and "something of this dignity still remains in the corpse." Another of his concerns was that "ordinarily the deed cannot be presented as a duty or as an obligatory act of charity." The liberty and spontaneity of the parties involved must be respected.

Other concerns that surfaced in discussions about the retrieval of organs from dead persons stemmed from factors other than the concept of transplantation per se. They included such things as: the high costs involved; questions about accurately determining the exact point of death of a donor and fears that some donors might not have actually died; and relatively high failure rates. (Ashley and O'Rourke, 1989, p. 305.)

Organ Transplantation by a Living Donor

Determining the moral acceptability of organ transplants between living persons proved to be a greater challenge for Catholic moral theologians of the 1940's and 1950's. The dilemma was initially framed in terms of the question as to whether a person could 'mutilate' him or herself for any purpose.

It has always been a fundamental tenet of Catholic teaching that the human body is under God's dominion and that we may not, therefore, dispose of it in any way we wish. Proper recognition of God's dominion calls for persons to exercise a sense of stewardship over their bodies. Consequently, all forms of mutilation - as well as suicide - were outlawed because they were deemed to be a violation of that dominion. In their attempts to resolve the quandary posed by "surgical mutilation", theologians such as St Thomas Aquinas (1225-1274) developed the Principle of Totality, a principle that by the middle of the 20th Century had become "an integral part of the moral methodology which had come to the fore in Catholic medical ethics." (Kelly, 1998, p. 305-306.) Put simply, the Principle of Totality, as articulated by Pope Pius XII in 1952, holds that the part exists for the whole. Consequently, it follows that the good of the part remains subordinated to the overall good of the whole. Therefore, the whole may be seen as a determining factor for the part, able to "dispose" of it in its own interest.

In its most common application, the Principle of Totality provided the logic used to justify the "surgical mutilation" of a person's body - for example the amputation of a gangrenous leg to save that person's life. However, its consistent application in this type of context also shaped the way in which the principle came to be understood, particularly when applied to other moral dilemmas. In Kelly's words, "the principle of totality had come to be limited to the physical good of the individual physical body." (1998, p. 306).

Interpreting the Principle of Totality in a physicalist and individualist way, most moral theologians were convinced that the surgical mutilation of any part of a person's body could only be justified for the better functioning of the person suffering the loss. Because persons are not related to each other as part to the whole (they each possess an innate and equal dignity), they drew the conclusion that surgical intervention was only ever permissible when an organ was harmful or useless to a particular person. The outcome seemed clear cut. The Principle of Totality ruled out live organ donation for philanthropic motives. It was on this basis that Pius XII proclaimed to a group of military surgeons in 1953: "The patient ... has no right to dispose of his own existence, of the integrity of his organism, of his particular organs and their functional capacity, except in the measure demanded by the good of the whole organism." Thus Kelly notes: "For a period of time Catholic moral theology was more apt to forbid [living donor] organ transplantation than to permit it." Indeed, there was almost unanimous agreement from Catholic moral theologians that the practice was morally unacceptable.

As early as 1944, however, (writing before organ transplantation was even possible) Bert Cunningham CM had posited an opposing point of view. Drawing on accepted Catholic thinking that recognised the validity of a person sacrificing his/her life in order to save the life of their "neighbour", Cunningham speculated that charity should be able to authorise something "less" than the taking of a human life. He therefore offered the "probable opinion" that living donor transplantation involved no opposition to the "natural or supernatural moral law" and that they were therefore licit.

In arguing his case Cunningham's central thesis was that living donor transplantation was not a violation of the Principle of Totality. The key problem, as he saw it, was that the Catholic Tradition was interpreting the principle in too narrow a way. Cunningham then proposed that the "body" be redefined to include not only the individual physical body from which the organ is removed, but the entire Mystical Body of Christ. Drawing moral implications from what was essentially a theological doctrine, he concluded that "... men are ordinated to society as parts to a whole, and, as such, are in some way ordinated to one another." This spiritual ordering would, he thought, allow any person to "mutilate" themselves physically for the overall good of the Mystical Body.

In analysing Cunningham's approach, other theologians seeking to develop a Catholic rationale for a more liberal opinion were wary of Cunningham's thesis that individuals are ordained to society as parts to the whole. In particular, his approach appeared unable to properly uphold the dignity and rights of the individual over their body and life, a failure that left the way open for the needs of individuals to be sacrificed in favour of the common good of the community. In the end, Shannon notes that it was Cunningham's "highlighting of the principle of charity rather than arguments about the unity of the human body – mystical or physical – that carried the argument supporting living organ donation." (2001, p. 289)

By 1955, there were enough moral theologians of sufficient stature within the Catholic community for Gerald Kelly SJ to conclude that living organ donation may be permitted. Kelly thought the Principle of Charity validated living donations provided that there was only "limited harm" to the donor. More recently, other theologians such as Ashley and O'Rourke have sought to justify the practice by drawing a distinction between "anatomical integrity" and "functional integrity": if one kidney is missing from a person's body, there is a lack of anatomical integrity, but if the other healthy kidney is present and working, the body retains its functional integrity because one healthy kidney is more than able to meet the body's needs. (Ashley and O'Rourke, 1989, p.306)

Most recently it was Pope John Paul II who articulated Catholic thinking on organ and tissue donation. In 1991 he described the therapeutic use of organ and tissue transplants as one of the many remarkable achievements of modern medicine. "It is surely a reason for satisfaction that many sick people, who recently could only expect death or at best a painful and restricted existence, can now recover more or less fully through the replacement of a diseased organ with a healthy donated one: We should rejoice that medicine, in its service to life, has found in organ transplantation a new way of serving the human family, precisely by safeguarding that fundamental good of the person." "We are challenged to love our neighbour in new ways; in evangelical terms, to love 'to the end' (cf Jn 13:1), yet within certain limits which cannot be exceeded." ("Many ethical, legal, and social questions must be examined in greater depth" (June 20, 1991) Dolentium Hominum, Vatican Press n. 3 pp. 12.)

For John Paul II, the limit which cannot be exceeded "above all" is that organ donation must remain "a human act of donation. In effect, transplantation presupposes a prior, explicit, free, and conscious decision on the part of the donor or of someone who legitimately represents the donor, generally the closest relatives." John Paul II exhorts health professionals involved not to lose sight of the donor's act of self-giving and "the mystery of love involved" in what they are doing. "Nor should the recipients of organ transplants forget they are receiving a unique gift from someone else: the gift of self made by the donor ... The progress of the biomedical sciences has made it possible for people to project beyond death their vocation to love." Subsequently, the donation of tissues and/or organs has come to be described by many as an "enduring gift".

On the question of living donations, John Paul II states that "a person can only donate that of which he can deprive him or herself without serious danger or harm to their own life or personal identity, and for a just and proportionate reason." "Vital" organs should only be donated after death.

Organ Transplantation and Compensation

In his 1956 teaching Pius XII was ambivalent as to whether one should "refuse on principle all compensation" for organ donation. While he did not doubt that grave abuses could occur when payments are demanded, he concluded that it was commendable for a donor to refuse recompense but "not necessarily a fault to accept it". John Paul II, meanwhile, advocated a firmer line; the provision of an organ should be "a decision to offer without reward a part of one's own body." John Paul II adopted this stance because of his belief that the commercialisation of body parts would amount to a materialist reduction of the human body.

Such a reductive materialist conception would lead to a merely instrumental use of the body, and therefore of the person. In such a perspective, organ transplantation and the grafting of tissue would no longer correspond to an act of donation but would amount to the dispossession or plundering of a body. (Address to participants in a conference on organ transplants, June 20, 1991)

Within New Zealand there has developed a strong culture of resistance to the notion of commercialising transactions involving human tissue. Unlike other parts of the world, New Zealanders have never received compensation for giving blood, for example. This attitude has been most recently enshrined in legislation such as the Human Assisted Reproductive Technology (HART) Act which prohibits the commercial supply of human embryos and human gametes and also prohibits commercial surrogacy arrangements.

One of the ways in which the notion of organ and tissue donation as 'gift' may continue to be upheld in law and practice in New Zealand is by ensuring that there are robust processes for recording a person's positive consent to be a donor.

The absence of specific consent raises the question as to whether anyone else can make a proxy decision in favour of organ donation for a dying person. At first glance, the concept of organ donation as an act of 'self-giving' might seem to rule out any notion of substituted or surrogate consent. In line with this, from the time of Pius XII, Catholic teaching has consistently maintained that "public authority" has no direct right to dispose of the existence and integrity of the organs of its innocent subjects. Nevertheless, Catholic teaching continues to affirm the right of the family or next-of-kin to make such a judgement. It does this on the basis that such persons are in a genuine position to know what their loved one would have wanted, and provided that the person concerned had not previously made known their opposition to such.

Conclusion

Moral theologians of the 1950's and 1960's faced new dilemmas as a result of technological and medical advances. The history of Catholic moral teaching on organ transplantation shows how the Catholic position on ethical issues sometimes develops over time. In this case there has been a movement from condemnation to commendation, from describing it as mutilation to describing it as donation, and from a very individualistic approach informed by the principles of Totality and Stewardship to a more social view of the issue informed by the principle of Charity. (Jonsen, 2005)

The initial responses of many theologians to the possibility of organ and tissue transplantation were both informed by, as well as limited by, existing principles and ways of thinking inherited from the moral tradition. In the light of condemnations of the practice, a few theologians were prepared to challenge the conclusions of the majority, among other things motivated by an "intuitive" sense that it seemed wrong to forbid transplantations. In developing a rationale for a more positive assessment of transplants they refined accepted principles and extended Catholic moral thinking.

In our own time we are facing many new dilemmas related to new advances in technology and medicine. We would do well to recall the history of the debate over organ and tissue transplantation as we seek to apply established moral principles to issues raised by reproductive technologies and developments in genetics and biotechnology.

The experience of theologians of the 1950's and 1960's should inspire us with boldness to contribute to the debates of our own time based on a confidence in our rich moral tradition. At the same time we should also bear a healthy sense of humility and scepticism, even (and perhaps especially) towards those solutions that seem so "obvious" and clear cut. We are also challenged to listen openly to those who propose alternative solutions.

In the meantime, the debate over how best to promote a more effective organ donation system in New Zealand continues. The legacy of John Paul II, Pius XII and many competent moral theologians places Catholics and others in an excellent position to contribute to the discussion. While the moral acceptability of organ and tissue transplantation is now a given, risks remain and ongoing ethical vigilance is required. In particular, future developments such as xenografting and transgenesis will surely require us to revisit the basic principles in order to resolve new questions and dilemmas that are bound to arise.

_____________________

John Kleinsman is a Researcher for The Nathaniel Centre

©
2006

Human Tissue (Organ Donation) Amendment Bill - July 2006

 

A Submission from The Nathaniel Centre – The New Zealand Catholic Bioethics Centre

General Comments

We are called to show the utmost respect to a person's body at all times, including after death. This respect is an ongoing expression of the dignity owed to each person on the basis of our shared humanity. To desecrate or in some way to violate someone's body is simultaneously to desecrate and violate the person. A person's body is integral to, rather than incidental to, their personal identity. In New Zealand this responsibility is reflected in the longstanding current law which holds that no one can ever "own" the body of another.

Read more...

HIV-AIDS: Understanding the Power of Stigma

 Issue 22, August 2007

Morality that is based on "abstract" notions of the good is inadequate. We are particular persons in a particular time with particular relationships. Our history, our story, our culture, shapes how we see God, how we see others, and how we see ourselves. All these factors shape our moral vision just as they also shaped the Sacred Scriptures which were themselves born of a particular time and place and cultural perspective.

Read more...

Conversations with Sister Paula Brettkelly – A Story about Dying

Issue 24, April 2008 

From October 2007 until early May 2008 I have had a number of conversations with Sister Paula Brettkelly about her experience of being terminally ill. Well known in the community for her work in human rights and her advocacy for those living with HIV-AIDS Sister Paula was invested in 2007 as a member of the New Zealand Order of Merit for Services to Human Rights.

Read more...

Hope and Despair: the Funding of Herceptin

Sharron Cole
Issue 25, August 2008

Since its arrival with much fanfare at an Oncology Conference in Florida in May 2005, the drug Herceptin (Trastuzumab) has scarcely been out of the news. It was, said its lead British investigator, "the biggest treatment development in breast cancer ... for at least the last 25 years, perhaps as big as anything we've seen". It is now a publicly funded drug, available in many countries, to women with HER2 positive breast cancer. But the funding of Herceptin has been, and continues to be dogged by controversy in many of those countries, particularly in New Zealand. Why is this and are there lessons to be learned?

Read more...

The Gardasil Vaccine – Is it Safe and Effective?

 

Issue 28, August 2009


Introduction

Gardasil, the latest vaccine to be added to the immunisation schedule of young New Zealanders, will soon be in its second year of administration within the community. It is funded and recommended for girls of twelve years of age with a catch-up programme offering the vaccine for girls and young women from 11 to 18 years of age. This 'cervical cancer' vaccine has caused controversy in ways different from previous vaccines, with objections to it ranging from fears that it is not safe to concern that it may increase promiscuity.

Read more...

Book Review - Health Cheque: The Truth we should all know about New Zealand's Public Health System

 Issue 30, April 2010

Authors: Gareth Morgan & Geoff Simmons

Publisher: Public Interest Publishing, 2009

Reviewer: John Kleinsman

The question of health care affordability is topical again.

Read more...

Ethics Committees – guardians of research participants’ rights or expediters of clinical research?

Sharron Cole

If the September response of the Government to the Health Select Committee's 'Inquiry into improving New Zealand's environment to support innovation through clinical trials' is implemented, there is the real likelihood that the role of regional health and disability ethics committees (HDEC) will become one of rubberstamping and expediting research rather than one of giving considered and principled analysis to ensure that the research is ethical and that there are adequate safeguards to protects the rights and interests of research participants.

The main aim of the Select Committee's inquiry was to ascertain how clinical trials and research proposals can be streamlined and how an effective clinical trials environment can be created. It identified the current system of ethical review as one of the main obstacles to delivering efficient clinical trial outcomes and made a large number of recommendations to radically alter the system of ethical review.

A number of submitters to the Select Committee inquiry, principally pharmaceutical companies and researchers, argued that the present ethical review system is 'overly bureaucratic' and that it is a hindrance to research, with one submitter arguing that it 'has become so unwieldy it is unethical'. Interestingly, submitters with an ethical expertise and a number of consumer groups argued that while the present process can always be improved (usually simply addressed by better resourcing), there was no evidence to suggest that the present system needed a major overhaul or to substantiate the allegations that the present system of ethical review was either flawed or a major hindrance to the carrying out of effective research.

Not all the Select Committee's fifty four suggestions have been taken up by the Government but it has accepted most of the recommendations which in summary are:

  • developing standardised operating procedures for ethics committees (to have effect from 1 July 2012). These standardised operating procedures will:
    • introduce timelines for full review (35 days) and expedited review (15 days)
    • expand the expedited review pathway to include some clinical trials, and clarify and reduce the scope of HDEC review as a whole (focus more narrowly on ethical issues)
    • reduce duplication by clarifying the roles of HDECs, researchers, localities, and the Standing Committee on Therapeutic Trials
    • define when amendments to approved studies themselves require HDEC review
  • developing shorter, simpler application forms (by mid-Jan 2012)
  • implementing an online application system, with a 'central clearing house' (by 1 July 2012)
  • reducing the number of committees from seven to four
  • reducing committee size from twelve to eight members, including at least three lay members

 

The main concern that emerges from the Government's acceptance of many of the committee's recommendations is that the present primary objective of ethical review to 'safeguard the rights and interests of participants in research and innovative practice, and consumers of health and disability services' will be diminished.

The present carefully constructed system, which has been shaped by New Zealand's unique society, protects research participants by having:

  1. Regionally-based ethics committees, in touch with and responsive to the needs of their local communities. The proposal to have fewer ethics committees will mean a move to a more centralised system with a loss of the unique advantages offered by the regional system.
  2. Regionally-based committees which allow local iwi to have input, in line with Treaty obligations. The place of the Treaty in the system of ethical review is unique to New Zealand and means the principles of the Treaty are honoured.
  3. Committees with twelve members, including six lay members, which give extensive scientific, medical, ethical, legal, disability, Maori and many other perspectives. It is the composition of ethics committees with people of different backgrounds each adding to the deliberation of ethical views that is one of the strengths of the present system. As C Wright Mills says, thinking in terms of a variety of viewpoints, "catching light from as many angles as possible."
  4. Independent scientific, research and medical expertise which means an assurance that the research has scientific integrity and strengthens the committee's understanding of the scientific and clinical issues and of risk/benefit, thus contributing to more ethical, stronger decision making. The government's proposal is to take away this expertise and for the investigator or sponsor to obtain peer review. This is of real concern as the pharmaceutical companies are significant funding sources for researchers, making it extremely difficult for investigators to obtain un-conflicted or independent review.

Since 2007, many observational studies have received expedited review as they are reviewed by only the chair or deputy chair. The Government now proposes that expedited review should be available not only for observational studies but also for some 'low risk clinical trials'. It is not clear who will determine which trials constitute 'low risk' and thus qualify for chair-only review but the spectre of exposure to unanticipated risk is certainly raised. The proposal to include clinical trials in expedited review is both puzzling and concerning as the National Ethics Advisory Committee, whose primary function is to provide advice to the Minister of Health on ethical issues of national significance, had in 2009 identified interventional clinical trials as having a greater potential to cause harm and thus requiring close ethical scrutiny.

Since 2002, I have given a number of presentations on the system of ethical review in New Zealand, noting the strengths as outlined above but also outlining my concerns:

  • Lessons of past quickly forgotten e.g.
    • Greenlane Hospital and collection of babies' hearts
    • Physiotherapy on babies at National Women's Hospital
  • Attempts to revise history – e.g. the 'Unfortunate Experiment'
  • Perception of lack of real commitment to, and understanding of, the importance of ethical review
  • Low priority given to ethical matters e.g. length of time to review Operational Standard, lack of resourcing, lack of advertising
  • 'Generalists' and vested interests appear to ignore the input of experienced working ethicists

As the New Zealand system of ethical review arose from the recommendations of the Cartwright Report, it behoves any reviewer to keep in mind Judge Cartwright's strong criticism of the poor quality of review surrounding clinical research at the time. She was fiercely critical, among many other things, of the lack of independence and impartiality of the Hospital Ethics Committee that approved Professor Green's research. She was pessimistic about the then existing medical establishment to develop a system of ethical review that would give adequate protection to research participants.

The ever shrinking and increasingly restricted nature of ethics committees since 2004, culminating in these proposed radical changes, makes it very difficult to be at all optimistic about the robustness of ethical review in the future.